Off-label use of combined antiretroviral therapy, analysis of data collected by the Italian Register for HIV-1 infection in paediatrics in a large cohort of children

BACKGROUND: Early start of highly active antiretroviral therapy (HAART) in perinatally HIV-1 infected children is the optimal strategy to prevent immunological and clinical deterioration. To date, according to EMA, only 35% of antiretroviral drugs are licenced in children < 2 years of age and 60%...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiappini, Elena, Lisi, Catiuscia, Giacomet, Vania, Erba, Paola, Bernardi, Stefania, Zangari, Paola, Di Biagio, Antonio, Taramasso, Lucia, Giaquinto, Carlo, Rampon, Osvalda, Gabiano, Clara, Garazzino, Silvia, Tagliabue, Claudia, Esposito, Susanna, Bruzzese, Eugenia, Badolato, Raffaele, Zanaboni, Domenico, Cellini, Monica, Dedoni, Maurizio, Mazza, Antonio, Pession, Andrea, Giannini, Anna Maria, Salvini, Filippo, Dodi, Icilio, Carloni, Ines, Cazzato, Salvatore, Tovo, Pier Angelo, de Martino, Maurizio, Galli, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760752/
https://www.ncbi.nlm.nih.gov/pubmed/35033018
http://dx.doi.org/10.1186/s12879-022-07026-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760752/
https://www.ncbi.nlm.nih.gov/pubmed/35033018
http://dx.doi.org/10.1186/s12879-022-07026-w

Ejemplares similares